Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan:191:106716.
doi: 10.1016/j.rmed.2021.106716. Epub 2021 Dec 14.

Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options

Md Mohiuddin  1 , Kazuo Kasahara  2
Affiliations
Editorial

Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options

Md Mohiuddin et al. Respir Med. 2022 Jan.

Abstract

The COVID-19 pandemic has put a strain on all the healthcare systems around the world. The World Health Organization (WHO) stated that the "highly mutated" Omicron variant, known as B.1.1.529, could represent a very high global risk of sudden increases in infections. As a result, it is urgently necessary to explore the most suitable treatments for this variant. The purpose of the study was to investigate the currently available studies regarding the Omicron variant and try to identify any potentially effective therapies for the Omicron variant.

PubMed Disclaimer

References

    1. Indari O., Jakhmola S., Manivannan E., Jha H.C. An update on antiviral therapy against SARS-CoV-2: How far have we come? Front. Pharmacol. 2021;12:632677. - PMC - PubMed
    1. Lee L.Y., Cazier J.B., Angelis V., Arnold R., Bisht V., Campton N.A., Chackathayil J., Cheng V.W., Curley H.M., Fittall M.W., Freeman-Mills L., Gennatas S., Goel A., Hartley S., Hughes D.J., Kerr D., Lee A.J., Lee R.J., McGrath S.E., Middleton C.P., Murugaesu N., Newsom-Davis T., Okines A.F., Olsson-Brown A.C., Palles C., Pan Y., Pettengell R., Powles T., Protheroe E.A., Purshouse K., Sharma-Oates A., Sivakumar S., Smith A.J., Starkey T., Turnbull C.D., Varnai C., Yousaf N., U.K.C.M.P. Team. Kerr R., Middleton G. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926. - PMC - PubMed
    1. Liu C., Zhao Y., Okwan-Duodu D., Basho R., Cui X. COVID-19 in cancer patients: risk, clinical features, and management. Cancer Biol. Med. 2020;17(3):519–527. - PMC - PubMed
    1. Moujaess E., Kourie H.R., Ghosn M. Cancer patients and research during COVID-19 pandemic: a systematic review of current evidence. Crit. Rev. Oncol. Hematol. 2020;150:102972. - PMC - PubMed
    1. Mohiuddin M., Kasahara K. Cancer Treatment and Research Communications; 2021. The Emerging Role of Cellular Senescence in Complications of COVID-19; p. 100399. - PMC - PubMed

Publication types

Supplementary concepts